The programmatic hemosorption in the comprehensive treatment of atherosclerosis of various localization. Hemosorption in the treatment of atherosclerosis.

The inclusion of hemosorption through activated coals into the comprehensive treatment of 580 patients sick with atherosclerosis has made it possible to achieve a positive clinical effect among 81 per cent of the patients sick with the ischemic heart disease, 79 per cent of atherosclerotic discirculatory encephalopathy and 76 per cent of obliterating atherosclerosis of lower limbs. The positive dynamics is especially visible among patients who are administered the programmatic hemosorption, making it possible over a long period of time (3-5 years) to sustain remission in the clinical state and the normal level of the lipids in the blood. The direct effect is expressed in the improved microcirculation, disappearance of the sludge-syndrome and the reduction of ischemic disorders.

[The serum enzymogram for the evaluation of the effectiveness of hemosorption in patients with acute destructive pancreatitis].

To evaluate the hemosorption efficacy in patients with acute destructive pancreatitis, the authors suggest an enzymogram consisting of 4 enzymatic tests: trypsin, trypsin inhibitor, gamma-glutamyltranspeptidase, pseudocholinesterase. It was demonstrated that these enzymes are highly informative, mirroring liver and pancreatic functions. After hemosorption these indicators were discovered to be improved as compared to those in controls.